BH-P-FLOAT

BH-P-FLOAT: A Phase I, first-in-human, open-label, dose escalation study of the safety, tolerability, pharmacokinetics, and immunogenicity of BNT317 in patients with advanced solid tumors

Status:

OPEN TO ACCRUAL

Trial Type:
Gastrointestinal, Genitourinary, Skin, Thoracic, Unknown Primary
Age Group:
Adults
Phase:

I

NCT Number:

NCT06750185

Contact:

Carneiro, Benedito

benedito.carneiro@BrownHealth.org